ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2481

Prevalence and Trends of Suicidal Ideation Among Hospitalized Adults with Systemic Lupus Erythematosus (SLE): A National Inpatient Sample Analysis (2016–2020)

Fatima Khdeir and Aysheh Khdeir, ECU Health Medical Center, Greenville, NC

Meeting: ACR Convergence 2025

Keywords: psychological status, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2470–2503) Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease associated with psychiatric comorbidities, including depression and suicidal ideation. However, national trends over time have not been fully characterized.

Methods: We conducted a retrospective cross-sectional analysis using NIS data from 2016–2020. Adult patients (age ≥18) diagnosed with SLE were identified using ICD-10 codes. Suicidal ideation was detected using diagnosis code R45.851. Weighted survey procedures were applied for national estimates. Secondary outcomes included age, sex, race, and psychiatric comorbidities such as generalized anxiety disorder, depression, bipolar disorder, and psychotic disorders.

Results: The total weighted number of SLE hospitalizations from 2016 to 2020 was approximately 245,300 patients. Among these, 1.31% had documented suicidal ideation. Patients with suicidal ideation were notably younger, with a mean age of 42.1 years, compared to 47.3 years among those without (p < 0.001). No significant differences were observed between males and females. However, there were clear racial disparities, with White patients accounting for the highest proportion of suicidal ideation cases (53.6%). Psychiatric comorbidities—including anxiety disorders, bipolar disorder, psychotic disorders, and substance abuse—were all significantly associated with increased suicidal ideation (p < 0.001). Trend analysis revealed that suicidal ideation cases rose from 675 in 2016 to a peak of 955 in 2017, before steadily declining to 350 in 2020. During the same period, overall SLE hospitalizations also showed a decreasing trend.

Conclusion: Although the overall rate of suicidal ideation among hospitalized SLE patients remains low, psychiatric comorbidities significantly increase risk. After a peak in 2017, a decreasing trend was observed through 2020, likely due to improved psychiatric screening, advances in SLE treatment, multidisciplinary care approaches, and increased recognition of neuropsychiatric risk factors.

Supporting image 1SLE hospitalizations (blue bars)

Suicidal ideations (red line)

From 2016 to 2020.


Disclosures: F. Khdeir: None; A. Khdeir: None.

To cite this abstract in AMA style:

Khdeir F, Khdeir A. Prevalence and Trends of Suicidal Ideation Among Hospitalized Adults with Systemic Lupus Erythematosus (SLE): A National Inpatient Sample Analysis (2016–2020) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/prevalence-and-trends-of-suicidal-ideation-among-hospitalized-adults-with-systemic-lupus-erythematosus-sle-a-national-inpatient-sample-analysis-2016-2020/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-trends-of-suicidal-ideation-among-hospitalized-adults-with-systemic-lupus-erythematosus-sle-a-national-inpatient-sample-analysis-2016-2020/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology